⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

PODD

Insulet Corporation

Healthcare · Medical Devices

137.92USD

-4.3600 (-3.06%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.59▼$1.64317
Next quarter$1.84▼$1.98019
Current year$6.5▲$6.46157
Next year$7.71▼$8.06121

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.45$1.66+0.21 (+14.3%)
2026-03-31$1.19$1.42+0.23 (+19.3%)
2025-12-31$1.46$1.55+0.09 (+6.0%)
2025-09-30$1.15$1.24+0.09 (+8.1%)

Wall Street coverage

316 ratings from 45 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Canaccord GenuityMaintainedBuy$249 $179Aug 6, 2026
Leerink PartnersDowngraded from OutperformMarket Perform$247 $145Aug 6, 2026
TD CowenMaintainedHold$294 $144Aug 6, 2026
UBSMaintainedNeutral$174 $150Aug 6, 2026
RBC CapitalMaintainedOutperform$245 $160Aug 6, 2026
BernsteinMaintainedOutperform$200 $175Aug 6, 2026
BenchmarkMaintainedBuy$250 $185Aug 6, 2026
StifelMaintainedBuy$225 $180Aug 6, 2026
Wells FargoDowngraded from OverweightEqual-Weight$255 $144Aug 6, 2026
JP MorganDowngraded from OverweightNeutral$275 $152Aug 6, 2026
BTIGDowngraded from BuyNeutral—Aug 6, 2026
Truist SecuritiesDowngraded from BuyHold$210 $153Aug 6, 2026
Truist SecuritiesMaintainedBuy$219 $210Jul 13, 2026
RBC CapitalMaintainedOutperform$280 $245Jul 13, 2026
StifelMaintainedBuy$250 $225Jul 10, 2026
CitigroupMaintainedNeutral$165 $172Jul 8, 2026
Evercore ISI GroupMaintainedOutperform$200 $180Jul 6, 2026
Deutsche BankInitiatedBuy$190Jun 23, 2026
Truist SecuritiesMaintainedBuy$250 $219Jun 12, 2026
CitigroupMaintainedNeutral$175 $165May 28, 2026
RBC CapitalReiteratedOutperform$280May 27, 2026
BTIGMaintainedBuy$260 $235May 27, 2026
B of A SecuritiesMaintainedBuy$288 $208May 18, 2026
BarclaysMaintainedUnderweight$286 $198May 8, 2026
Canaccord GenuityMaintainedBuy$435 $249May 7, 2026

Insider transactions

93 filings from 22 insiders · 15 buy / 1 sell over 6m

Officers and directors of PODD, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
MAZELSKY JONATHAN JAYDirectorGrant1.4k——Jul 1, 2026
HUFFINES ROBERT LUTHERDirectorGrant151$152.25$23kJun 30, 2026
HUFFINES ROBERT LUTHERDirectorGrant144$159.79$23kJun 30, 2026
BORIO LUCIANADirectorSell418$143.27$60kJun 3, 2026
WEATHERMAN ELIZABETH HDirectorBuy3.5k$144.20$497kJun 3, 2026
STONESIFER TIMOTHY CDirectorBuy2.8k$143.51$400kJun 3, 2026
BORIO LUCIANADirectorGrant1.7k——May 20, 2026
FREDERICK WAYNE A.I.DirectorGrant1.7k——May 20, 2026
SCANNELL TIMOTHY J.DirectorGrant1.7k——May 20, 2026
MINOGUE MICHAEL RDirectorGrant1.7k——May 20, 2026
HUFFINES ROBERT LUTHERDirectorGrant1.7k——May 20, 2026
STONESIFER TIMOTHY CDirectorGrant1.7k——May 20, 2026
HOPFIELD JESSICADirectorGrant1.7k——May 20, 2026
WEATHERMAN ELIZABETH HDirectorGrant1.7k——May 20, 2026
PANOS MICHAELOfficerGrant2.8k——Apr 1, 2026
HUFFINES ROBERT LUTHERDirectorGrant111$209.84$23kMar 31, 2026
MINOGUE MICHAEL RDirectorBuyindirect2.0k$246.23$500kFeb 25, 2026
KAPPLES JOHN W.General CounselGrant1.9k——Feb 24, 2026
BUDDEN LAURENOfficerGrant611——Feb 24, 2026
MCEVOY ASHLEYChief Executive OfficerGrant10.0k——Feb 24, 2026

Analyst Notes

Sign in to write

No analyst notes on PODD yet.

Analyst Ratings

22 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current4111000Buy2.24
1 mo ago516400Buy1.96
2 mo ago418300Buy1.96
Price target$171.91$144.00 – $275.00
+24.6% to target